Christof Hettich
Chairman chez HEIDELBERG PHARMA AG
Profil
Dr. Christof Hettich is Chairman-Supervisory Board at WILEX AG, Chairman-Supervisory Board at Agennix AG, a Managing Director at Health Sciences GmbH & Co. KG, Chairman-Supervisory Board at InterComponentWare AG, Partner at RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB, a Managing Director at dievini Hopp BioTech holding GmbH & Co. KG, Chairman at Stiftung ProJustitia, a Managing Director at dievini Verwaltungs GmbH, a Managing Director at NewMarket Venture Verwaltungs GmbH, a Managing Director at RITTERSHAUS Management und Beteiligungs GmbH, a Managing Director at RITTERSHAUS Steuerberatungsgesellschaft mbH, Non-Executive Chairman at Febit, Inc., Chairman-Supervisory Board at SRH Holding GmbH, and Chairman-Supervisory Board at Hussel GmbH.
He is on the Board of Directors at AC Immune SA, LTS LOHMANN Therapie-Systeme AG, Nationaltheater Mannheim Foundation, Immatics Biotechnologies GmbH, and Franz Haniel & Cie.
GmbH.
Dr. Hettich was previously employed as Chairman-Supervisory Board by Actris AG, Chairman-Supervisory Board by J.F.
Müller & Sohn AG, Chairman-Supervisory Board by PARK & Bellheimer AG, Deputy Chairman-Supervisory Board by SYGNIS Pharma AG, a Managing Director by Bohlini GmbH & Co. KG, a Managing Director by Bohlini Verwaltungs GmbH, a Managing Director by Curacyte GmbH, a Managing Director by JUPEC Verlags GmbH, a Member-Supervisory Board by Eichbaum-Brauereien AG, a Member-Supervisory Board by Heidelberg Pharma AG, and a Member-Supervisory Board by SRH Kliniken GmbH.
He also served on the board at CureVac AG.
He received his undergraduate degree from the University of Freiburg, a graduate degree from the University of Freiburg, and a doctorate degree from Julius-Maximilians-Universität Würzburg.
Postes actifs de Christof Hettich
| Sociétés | Poste | Début |
|---|---|---|
| HEIDELBERG PHARMA AG | Chairman | 28/10/2011 |
SRH Kliniken GmbH
 SRH Kliniken GmbH Hospital/Nursing ManagementHealth Services Part of SRH Holding (SdbR), SRH Kliniken GmbH is a healthcare company that operates multiple clinics across Germany, including locations in Gera, Karlsbad-Langensteinbach, Bad Wimpfen, Neresheim, Oberndorf a.N., Bad Kösen, and others. The private company is based in Heidelberg, Germany. The company provides medical services and treatments to patients in these regions. The CEO of the company is Werner Stalla. | Chairman | - |
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Chairman | - |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Director/Board Member | - |
| RITTERSHAUS Steuerberatungsgesellschaft mbH | Chief Executive Officer | - |
SRH Higher Education GmbH
 SRH Higher Education GmbH Miscellaneous Commercial ServicesCommercial Services SRH Higher Education GmbH engages in the operation of universities. It aims to promote vocational training, science, and research. The firm also has the objective of promoting the public health system and public healthcare, welfare services for young people and the elderly, general education, and social welfare. The company is headquartered in Heidelberg, Germany. | Chief Executive Officer | - |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Chairman | - |
| Febit, Inc. | Chairman | - |
SRH Holding (SdbR)
 SRH Holding (SdbR) Other Consumer ServicesConsumer Services SRH Holding engages in the provision of educational and health care services. It operates universities, vocational schools, vocational rehabilitation centers, acute care hospitals, rehabilitation clinics, and outpatient care centers. The company was founded in 1966 and is headquartered in Heidelberg, Germany. | Chief Executive Officer | 01/02/2015 |
| ░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Christof Hettich
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Christof Hettich
| University of Freiburg | Graduate Degree |
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| 2INVEST AG | Finance |
| AC IMMUNE SA | Health Technology |
| PARK & BELLHEIMER AG | Consumer Non-Durables |
| HEIDELBERG PHARMA AG | Health Technology |
| IMMATICS N.V. | Health Technology |
| Entreprise privées | 33 |
|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Actris AG
 Actris AG Food DistributorsDistribution Services Actris Ag's develops and manages real estate properties. The firm also produces and distributes beer. The company is headquartered in Mannheim, Germany | Distribution Services |
Franz Haniel & Cie. GmbH
 Franz Haniel & Cie. GmbH Investment ManagersFinance Franz Haniel & Cie. GmbH is a Haniel family equity firm. The company was founded in 1756 by Jan Willem Noot and is headquartered in Duisburg, Germany. | Finance |
Privatbrauerei Eichbaum GmbH & Co. KG
 Privatbrauerei Eichbaum GmbH & Co. KG Beverages: AlcoholicConsumer Non-Durables Privatbrauerei Eichbaum GmbH & Co. KG engages in production of beers. The firm offers UREICH, classic, wheat, Wild monkeys, and Brewmaster still beers. The firm was founded on October 3, 1679 and is headquartered in Mannheim, Germany. | Consumer Non-Durables |
Curacyte AG
 Curacyte AG Miscellaneous Commercial ServicesCommercial Services Curacyte AG develops and markets biopharmaceutical solutions. The firm specializes in the development of new therapeutics for acute and critical care applications. Its focus areas cover applications in hematology, antithrombosism, and oncology. Its pipeline and development portfolio encompasses technologies, such as hemoximers, distributive shock, cardiogenic shock, plasmin and plasma kallikrei, matriptase, and high-dose interleukin-2 therapy. The company was founded in February 2000 and is headquartered in Munich, Germany. | Commercial Services |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
J.F. Müller & Sohn AG
 J.F. Müller & Sohn AG Forest ProductsNon-Energy Minerals J.F. Müller & Sohn AG manufactures hardwood veneer, softwood veneer, and plywood. The company was founded by Friedrich Jacob Müller in 1795 and is headquartered in Hamburg, Germany. | Non-Energy Minerals |
InterComponentWare AG
 InterComponentWare AG Packaged SoftwareTechnology Services InterComponentWare AG provides technology solutions for the healthcare market. Its products include ICW Master Patient Index, ICW Professional Exchange Server and ICW Care Manager. The firm serves the hospitals, care providers and care management companies. The company was founded in October 26, 1998 and is headquartered in Walldorf, Germany. | Technology Services |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Health Technology |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Finance |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
Agennix AG
 Agennix AG BiotechnologyHealth Technology Agennix AG was a pharmaceutical company, which engaged in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs included oral talactoferrin alfa and RGB-286638. The company was founded in 1993 and was headquartered in Heidelberg, Germany. | Health Technology |
| Health Sciences GmbH & Co. KG | |
| Febit, Inc. | |
Weinheim 216 GmbH & Co. KG
 Weinheim 216 GmbH & Co. KG BiotechnologyHealth Technology Weinheim 216 GmbH & Co. KG operates as a cellular therapy company involving primary human hepatocytes. The company is headquartered in Weinheim, Germany. | Health Technology |
SRH Kliniken GmbH
SRH Kliniken GmbH Hospital/Nursing ManagementHealth Services Part of SRH Holding (SdbR), SRH Kliniken GmbH is a healthcare company that operates multiple clinics across Germany, including locations in Gera, Karlsbad-Langensteinbach, Bad Wimpfen, Neresheim, Oberndorf a.N., Bad Kösen, and others. The private company is based in Heidelberg, Germany. The company provides medical services and treatments to patients in these regions. The CEO of the company is Werner Stalla. | Health Services |
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
 RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services. | Commercial Services |
| Stiftung ProJustitia | |
| Nationaltheater Mannheim Foundation | |
| dievini Verwaltungs GmbH | |
NewMarket Venture Verwaltungs GmbH
 NewMarket Venture Verwaltungs GmbH Miscellaneous Commercial ServicesCommercial Services NewMarket Venture Verwaltungs GmbH provides management services. The private company is based in Mannheim, Germany. The German company was founded in 2000. The CEO is Christof Hettich. | Commercial Services |
RITTERSHAUS Management und Beteiligungs GmbH
 RITTERSHAUS Management und Beteiligungs GmbH Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Management und Beteiligungs GmbH provides management services. The private company is based in Mannheim, Germany. The CEO of the German company is Christof Hettich. | Commercial Services |
| JUPEC Verlags GmbH | |
| RITTERSHAUS Steuerberatungsgesellschaft mbH | |
| Bohlini GmbH & Co. KG | |
| Bohlini Verwaltungs GmbH | |
Molecular Health GmbH
Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Commercial Services |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Technology Services |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Health Technology |
SRH Higher Education GmbH
SRH Higher Education GmbH Miscellaneous Commercial ServicesCommercial Services SRH Higher Education GmbH engages in the operation of universities. It aims to promote vocational training, science, and research. The firm also has the objective of promoting the public health system and public healthcare, welfare services for young people and the elderly, general education, and social welfare. The company is headquartered in Heidelberg, Germany. | Commercial Services |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Health Services |
SRH Holding (SdbR)
SRH Holding (SdbR) Other Consumer ServicesConsumer Services SRH Holding engages in the provision of educational and health care services. It operates universities, vocational schools, vocational rehabilitation centers, acute care hospitals, rehabilitation clinics, and outpatient care centers. The company was founded in 1966 and is headquartered in Heidelberg, Germany. | Consumer Services |
Heidelberg Pharma AG /Old/
 Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Commercial Services |
